At a glance
ClinicalIndex Comparison RecordN/ACompleted· 291 enrolled
Drug / intervention
Extended Infusion Setdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Extended Wear Infusion Set (EWIS) in Patients With Type 1 Diabetes
In Brief
A clinical study evaluating Extended Infusion Set for Diabetes. Completed, enrolled 291 participants across 15 sites.
Detailed Summary
The purpose of this study is to collect confirmatory clinical data to support 6 or 7 days wear of EWIS (Extended Wear Infusion Set).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartOct 2019
Primary CompletionNov 2020
TodayJul 2026
First PostedOct 3, 2019
Enrollment StartOct 14, 2019
Primary CompletionNov 5, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.7 years ago
Interventions
Extended Infusion Setdevice
Each subject is asked to wear each Extended Wear Infusion Set for at least 174 hours.